Hepatitis C virus (HCV)-related cryoglobulinemia: Cryoglobulin type and anti-HCV profile

Clinical and Vaccine Immunology

Volumn 20, Issue 5, 2013, Pages 698-703

  Minopetrou, Martha ^a   Hadziyannis, Emilia ^a   Deutsch, Melanie ^a   Tampaki, Maria ^a   Georgiadou, Asimina ^a   Dimopoulou, Eleni ^a   Vassilopoulos, Dimitrios ^a   Koskinas, John ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; EPITOPE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PEGINTERFERON; RIBAVIRIN;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CRYOGLOBULINEMIA; CRYOPRECIPITATION; DISEASE ASSOCIATION; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; IMMUNOFIXATION ELECTROPHORESIS; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOMA; MALE; NONHUMAN; PRIORITY JOURNAL; VIRUS CORE;

ADULT; AGED; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; RNA HELICASES; SERINE ENDOPEPTIDASES; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84876850070     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00720-12     Document Type: Article

References (45)

1. Suzuki T, Ishii K, Aizaki H, Wakita T. 2007. Hepatitis C viral life cycle. Adv. Drug Deliv. Rev. 59:1200-1212. (Pubitemid 350030324)
2. Charles ED, Dustin LB. 2009. Hepatitis C virus-induced cryoglobulinemia. Kidney Int. 76:818-824.
3. Pozzato G, Zorat F, Bonetto S, Mazzaro C. 2011. Hepatitis C virus and non-Hodgkin's lymphoma: biology, epidemiology and therapy. Oncol. Rev. 5:249-260.
4. Pawlotsky JM. 2004. Pathophysiology of hepatitis C virus infection and related liver disease. Trends Microbiol. 12:96-102.
5. Dore MP, Fattovich G, Sepulveda AR, Realdi G. 2006. Cryoglobulinemia related to hepatitis C virus infection. Dig. Dis. Sci. 52:897-907.
6. Lake-Bakaar G, Jacobson I, Talal A. 2012. B cell activating factor (BAFF) in the natural history of chronic hepatitis C virus liver disease and mixed cryoglobulinaemia. Clin. Exp. Immunol. 170:231-237.
7. Schamberg NJ, Lake-Bakaar GV. 2007. Hepatitis C virus-related mixed cryoglobulinemia: pathogenesis, clinical manifestations, and new therapies. Gastroenterol. Hepatol. (N Y) 3:695-703. (Pubitemid 47605661)
8. Sargur R, White P, Egner W. 2010. Cryoglobulin evaluation: best practice? Ann. Clin. Biochem. 47:8-16.
9. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. 1974. Biological and clinical significance of cryoglobulins: a report of 86 cases. Am. J. Med. 57:775-788.
10. Dammacco F. 2012. HCV infection and cryoglobulinemia. Springer-Verlag Italia, Milan, Italy
11. Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, Tavoni A, Zignego AL, De Vita S. 2011. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun. Rev. 11:48-55.
12. Sneller MC, Hu Z, Langford CA. 2012. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virusassociated cryoglobulinemic vasculitis. Arthritis Rheum. 64:835-842.
13. De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, Campanini M, Naclerio C, Tavoni A, Pietrogrande M, Ferri C, Mascia MT, Masolini P, Zabotti A, Maset M, Roccatello D, Zignego AL, Pioltelli P, Gabrielli A, Filippini D, Perrella O, Migliaresi S, Galli M, Bombardieri S, Monti G. 2012. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum. 64:843-853.
14. Clair St. EW. 2012. Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy. Arthritis Rheum. 64:604-608.
15. Sène D, Ghillani-Dalbin P, Amoura Z, Musset L, Cacoub P. 2009. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitisCvirus-induced vasculitis. Arthritis Rheum. 60:3848-3855.
16. Ramos-Casals M, Stone JH, Cid MC, Bosch X. 2012. The cryoglobulinaemias. Lancet 379:348-360.
17. Sansonno D, Dammacco F. 2005. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect. Dis. 5:227-236. (Pubitemid 40410068)
18. Terrier B, Cacoub P. 2013. Cryoglobulinemia vasculitis: an update. Curr. Opin. Rheumatol. 25:10-18.
19. Sautto G, Mancini N, Solforosi L, Diotti RA, Clementi M, Burioni R. 2012. HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role. Clin. Dev. Immunol. 2012:1-11.
20. Marcucci F, Mele A. 2011. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 117:1792-1798.
21. Invernizzi F, Galli M, Serino G, Monti G, Meroni PL, Granatieri C, Zanussi C. 1983. Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. Acta Haematol. 70:73-82. (Pubitemid 13076858)
22. Ohsawa M, Shingu N, Miwa H, Yoshihara H, Kubo M, Tsukuma H, Teshima H, Hashimoto M, Aozasa K. 1999. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int. J. Cancer 80:237-239. (Pubitemid 29001727)
23. Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA. 2007. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297:2010-2017. (Pubitemid 46740353)
24. Kawamura Y, Ikeda K, Arase Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Suzuki F, Suzuki Y, Kumada H. 2007. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Am. J. Med. 120:1034-1041. (Pubitemid 350166219)
25. Ohtsubo K, Sata M, Kawaguchi T, Morishige S, Takata Y, Oku E, Imamura R, Seki R, Hashiguchi M, Osaki K, Yakushiji K, Kanaji T, Yoshimoto K, Ueno T, Okamura T. 2009. Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients. Int. J. Hematol. 89:452-459.
26. De Re V, De Vita S, Sansonno D, Gasparotto D, Simula MP, Tucci FA, Marzotto A, Fabris M, Gloghini A, Carbone A, Dammacco F, Boiocchi M. 2006. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. Rheumatology (Oxford) 45:685-693. (Pubitemid 43985336)
27. de Re V, Simula MP, Pavan A, Garziera M, Marin D, Dolcetti R, de Vita S, Sansonno D, Geremia S, Toffoli G. 2009. Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations. Ann. N. Y. Acad. Sci. 1173:152-160.
28. Sansonno D, Lauletta G, Nisi L, Gatti P, Pesola F, Pansini N, Dammacco F. 2003. Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin. Exp. Immunol. 133:275-282. (Pubitemid 36918603)
29. Maillard P, Lavergne JP, Sibéril S, Faure G, Roohvand F, Petres S, Teillaud JL, Budkowska A. 2009. Fcgamma receptor-like activity of hepatitis C virus core protein. J. Biol. Chem. 279:2430-2437. (Pubitemid 38114226)
30. Kanduc D, Tessitore L, Lucchese G, Kusalik A, Farber E, Marincola FM. 2008. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response. Cancer Immunol. Immunother. 57:1215-1223.
31. Hu YW, Rocheleau L, Larke B, Chui L, Lee B, Ma M, Liu S, Omlin T, Pelchat M, Brown EG. 2005. Immunoglobulin mimicry by hepatitis C virus envelope protein E2. Virology 332:538-549. (Pubitemid 40179192)
32. Ferri S, Dal Pero F, Bortoletto G, Bianchi FB, Lenzi M, Alberti A, Gerotto M. 2006. Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia. J. Viral Hepat. 13:166-176.
33. Hartmann H, Schott P, Polzien F, Mihm S, Uy A, Kaboth U, Pardowitz I, Ramadori G. 1995. Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates. Z. Gastroenterol. 33:643-650.
34. De Re V, Sansonno D, Simula MP, Caggiari L, Gasparotto D, Fabris M, Tucci FA, Racanelli V, Talamini R, Campagnolo M, Geremia S, Dammacco F, De Vita S. 2006. HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia 20:1145-1154. (Pubitemid 43797310)
35. Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, Longombardo G, Lombardini F, Bombardieri S, Gentilini P. 1996. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann. Intern. Med. 124:31-34. (Pubitemid 26019622)
36. Ramos-Casals M, Forns X, Brito-Zerón P, Vargas A, Ruiz M, Laguno M, Yagüe J, Sánchez-Tapias JM, Gatell JM, Font J. 2007. Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection. J. Viral Hepat. 14:736-742. (Pubitemid 47414934)
37. Crovatto M, Ceselli S, Mazzaro C, Modolo ML, Martelli P, Mazzi G, Pozzato G, Giannini F, Barbisin M, Chiarotto B, Santini GF. 1995. HCV genotypes and cryoglobulinemia. Clin. Exp. Rheumatol. 13(Suppl 13):S79-S82.
38. Sinico RA, Ribero ML, Fornasieri A, Renoldi P, Zhou J, Fasola M, Portera G, Arrigo G, Gibelli A, D'Amico G, Taggera A. 1995. Hepatitis Cvirus genotype in patients with essential mixed cryoglobulinaemia.QJM 88:805-810.
39. Zehender G, de Maddalena C, Monti G, Ballare M, Saccardo F, Piconi S, Invernizzi F, Monteverde A, Galli M. 1995. HCV genotypes in bone marrow and peripheral blood mononuclear cells of patients with mixed cryoglobulinemia. Clin. Exp. Rheumatol. 13(Suppl 13):S87-S90.
40. Monteverde A, Ballarè M, Pileri S. 1997. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin. Immunopathol. 19:99-110. (Pubitemid 27417531)
41. Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F. 1998. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J. Immunol. 160:3594-3601. (Pubitemid 28164756)
42. Sautto G, Mancini N, Clementi M, Burioni R. 2012. Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII). Viruses 4:2924-2944.
43. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, Velankar M, Nathwani BN, Fong TL. 1997. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann. Intern. Med. 127:423-428. (Pubitemid 27400904)
44. Nguyen QT, Leruez-Ville M, Ferrière F, Cohen P, Roulot-Marullo D, Coste T, Dény P, Guillevin L. 1998. Hepatitis C virus genotypes implicated in mixed cryoglobulinemia. J. Med. Virol. 54:20-25. (Pubitemid 28059059)
45. Vassilopoulos D, Younossi ZM, Hadziyannis E, Boparai N, Yen- Lieberman B, Hsi E, Villa-Forte A, Ball E, Kimberly RP, Calabrese LH. 2003. Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations. Clin. Exp. Rheumatol. 21(6 Suppl 32):S101-S111. (Pubitemid 38016487)